Next, because in some tumors, Jag1 signaling sustains tumor growth11, we analyzed whether upon IL-4 treatment, the decreased levels of Jag1 fragments, observed after blocking Notch–Jag1 interactions, could be accompanied by reduced cell viability. This evidence concerns the gene JAG1 and neoplasm.